跳转至内容
Merck
CN

EHU158371

MISSION® esiRNA

targeting human TREH, PHLDB1

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.51
UNSPSC Code:
41105324
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CTCCATCCCCTAGTTGCAGACTCATCACCATGGTTACCATAGTGACTGCTTCATTGCCATGGTTACATACTAATTGCTGCAGCTCTGTGGCCCAGCCCACTGCTTCAGCTGTGGGCCATCTGAGGGTACGTGCCATCATCTCTCCAGCCCAGGCCCCTGGGCATCTCATGCTGGGGGGAAGGGACTGAATACCTTTTTCCTTCCCCCTGCCTGTGTCTTCAGCCCTGATGCACAGGCTGCCAGCCCCCCAGTCCAGCCCTCTCCCTTCCACTGGTGCCTTGCTTAGAGCCAGAAGGGATGAAGCCGGGGGATCTATGGAACAGAGGAGGAGCGATGCAGTTGGGAGAGGAAGCTAGAAGGGTTATGGTTGGAGTTCTGTACAGTGTTGAGTTTCCGACAGGGAA

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Rebekah Baskin et al.
Scientific reports, 5, 17367-17367 (2015-11-28)
Glioma is the most common malignant primary brain tumor and is associated with poor prognosis. Genetic factors contributing to glioma risk have recently been investigated through genome-wide association studies (GWAS), implicating seven independent glioma risk loci in six chromosomal regions.



全球贸易项目编号

货号GTIN
EHU158371-20UG04061828644599
EHU158371-50UG04061828409983